Evaluation of Neutrophil/Lymphocyte Ratio ,Platelet/Lymphocyte Ratio and CRP as Markers of Severity of Pre-eclampsia

Ain Shams University

Status: Unknown

Conditions: Pre-Eclampsia

Treatments: Diagnostic Test: Neutrophil/lymphocyte ratio, Platelet /lymphocyte ratio and CRP

Study type: Interventional

Funder types: Other

Identifiers

NCT03630276

Shaza Elreweny

Details and patient eligibility

About

Evaluation of neutrophil/lymphocyte ratio, Platelet /lymphocyte ratio and CRP as markers of severity of Pre-eclampsia

Enrollment: 111 estimated patients

Sex: Female

Ages: 25 to 45 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• PREECLAMPSIA from 25_45years

Exclusion criteria

• chronic diseases Primary hypertension

Trial design

Primary purpose: Diagnostic

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: Single Blind

---

111 participants in 3 patient groups

Neutrophil/lymphocyte ratio

Other group

Treatment:

Diagnostic Test: Neutrophil/lymphocyte ratio, Platelet /lymphocyte ratio and CRP

Platelet/lymphocyte ratio

Other group

Treatment:

Diagnostic Test: Neutrophil/lymphocyte ratio, Platelet /lymphocyte ratio and CRP

CRP

Other group

Treatment:

Diagnostic Test: Neutrophil/lymphocyte ratio, Platelet /lymphocyte ratio and CRP